Reaction #1726716

ord-069857009ea74cb1a94fa9db8f392fbb

Conditions

Detailed conditions
See reaction.notes.procedure_details.

Workup

  1. 1
    Temperatureis refluxed for 72 hr
  2. 2
    OtherThe MeOH is removed by rotoevapoation, and DCM
  3. 3
    workup.ADDITIONis added to the residue
  4. 4
    FiltrationInsoluble material is filtered off
  5. 5
    Concentrationthe filtrate is concentrated by rotoevaporation
  6. 6
    OtherThe residue is purified by preparative TLC

Procedure

A mixture of 125 mg (0.64 mmol) of methyl 3-carbamoyl-4-hydroxybenzoate, 192 mg (0.96 mmol) of 1-Boc-4-piperidone, and 120 μL of morpholine in 10 mL of MeOH is refluxed for 72 hr. The MeOH is removed by rotoevapoation, and DCM is added to the residue. Insoluble material is filtered off, and the filtrate is concentrated by rotoevaporation. The residue is purified by preparative TLC to give 93 mg (0.25 mmol, 39% yield) of 1′-(tert-butyloxycarbonyl)-6-methoxycarbonylspiro[1,3-benzoxazine-2,4′-piperidine]-4(3H)-one which on treatment with 40% TFA in dichloromethane gives the TFA salt of 6-methoxycarbonylspiro[1,3-benzoxazine-2,4′-piperidine]-4(3H)-one in quantitative yield.

Source

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08110570B2uspto-grants-2012_02